Results 171 to 180 of about 24,692 (192)

The effect of daily use of brimonidine tartrate on the dark-adapted pupil diameter

American Journal of Ophthalmology, 2004
To investigate the effect of daily brimonidine tartrate 0.15% on the dark-adapted pupil diameter.Observational case series.Ten normal volunteers administered brimonidine to their right eyes once daily. Four to six hours later, infrared pupil photographs were taken after dark adaptation.
Sandra M. Brown, Arshad M. Khanani, David L. McCartney   +2 more
openaire   +3 more sources

Miotic effect of brimonidine tartrate 0.15% ophthalmic solution in normal eyes

Journal of Cataract and Refractive Surgery, 2004
To evaluate the effect of brimonidine tartrate 0.15% ophthalmic solution (Alphagan P) on pupil diameter in eyes of healthy adults under different luminance conditions.Center for Refractive Surgery, Ophthalmology Service, Department of Surgery, Walter Reed Army Medical Center, Washington, DC, USA.Using a Colvard pupillometer, the pupil diameter was ...
Brent B Warren, John E. Thordsen, Richard D. Stutzman, Kraig S. Bower   +3 more
openaire   +3 more sources

Sedative and physiological effects of brimonidine tartrate ophthalmic solution in healthy cats

Veterinary Anaesthesia and Analgesia, 2017
To determine the effects of brimonidine tartrate ophthalmic solution on sedation, heart rate (HR), respiratory frequency (fR), rectal temperature (RT) and noninvasive mean arterial pressure (MAP) in healthy cats.Randomized, blinded crossover study, with 1 week washout between treatments.Six healthy purpose-bred cats.Brimonidine tartrate ophthalmic ...
Niwako Ogata, Waka Morimitsu, Takayasu Ichikawa, Takamasa Itoi, Yukiko Nishino, Yuki Matsumoto, Mizuki Kawahata, Kayo Furumoto, Teppei Kanda   +8 more
openaire   +3 more sources

Increasing efficacy and reducing systemic absorption of brimonidine tartrate ophthalmic gels in rabbits

Pharmaceutical Development and Technology, 2017
Systemic absorption of ocularly administered Brimonidine Tartrate has been reported to give rise to several side-effects. Hence, it has become crucial to develop a delivery system that could increase efficacy and reduce systemic absorption. Therefore, the present work aims to develop Brimonidine Tartrate gels with different concentrations (0.05%, 0.1%,
Jiaxin Pi, Dongli Qi, Pan Guo, Xiaochen Pang, Jiawei Li, Yumei Wu, Nan Li, Zhidong Liu   +7 more
openaire   +2 more sources

COMPARATIVE EVALUATION OF POLYMER COMBINATION IN THE DESIGN OF BRIMONIDINE TARTRATE OCULAR INSERTS

INDIAN DRUGS, 2012
Brimonidine is an anti-glaucoma agent useful in treatment of intraocular pressure. In the present study an attempt was made to formulate ophthalmic inserts of brimonidine tartrate (BT) in combination with polymers like methylcellulose, carboxymethyl chitosan and HPMC. Prepared ocular films were evaluated for uniformity in thickness, weight variation, %
R Udupi, D. Hiremath, P Goudanavar, N Ambhore   +3 more
openaire   +1 more source

Allergic contact dermatitis probably due to brimonidine tartrate in eyedrops

Contact Dermatitis, 2021
Napolitano, Maddalena, Potestio, Luca, Castagliola, Ciro, Fabbrocini, Gabriella, Patruno, Cataldo   +4 more
openaire   +5 more sources

Additive effects of brimonidine tartrate 0.1%/brinzolamide 1% fixed-dose combination in prostaglandin analog-treated Japanese glaucoma patients

Japanese Journal of Ophthalmology, 2023
R. Sakata, S. Mizoue, K. Yoshikawa, Misato Adachi, S. Ohkubo, N. Hamada, Tomoko Naito, Tomoyuki Muramatsu, Takeshi Hara, Ryo Asato, M. Aihara   +10 more
semanticscholar   +1 more source

Formulation and evaluation of ocular self-nanoemulsifying drug delivery system of brimonidine tartrate

Journal of Drug Delivery Science and Technology, 2023
Bala Vikash, Shashi, N. K. Pandey, B. Kumar, Sheetu Wadhwa, Umesh Goutam, Aftab Alam, Faisal Al-Otaibi, Pramila Chaubey, G. Mustafa, G. Gupta, K. Dua, Sachin Kumar Singh   +12 more
semanticscholar   +1 more source

Evaluation of Physical Properties and Usability of Brimonidine Tartrate Ophthalmic Solution for the Treatment of Glaucoma in Brand-name and Generic Drug Formulations

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 2023
Shigeo Akiyama, Masaaki Yoneda, Etsuko Miyamoto, C. Maida, Shiro Ishida, Yusuke Hori, Nobuyuki Doi   +6 more
semanticscholar   +1 more source

Efficacy and safety of fixed-combination brimonidine tartrate/timolol maleate in primary open-angle glaucoma, including normal-tension glaucoma

Japanese Journal of Ophthalmology, 2021
Sang Woo Park, J. Kim, Ji Woong Lee, Joy Maglambayan, S. Simonyi, K. Park   +5 more
semanticscholar   +1 more source